A Study of Ipatasertib in Combination With Atezolizumab and Paclitaxel as a Treatment for Participants With Locally Advanced or Metastatic Triple-Negative Breast Cancer
Clinical trial NCT04177108 · COMPLETED
Trial details
- NCT number
- NCT04177108
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-25
- Primary completion
- 2023-02-28
- Enrollment
- 242
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.